Your browser doesn't support javascript.
loading
Plasma sphingolipids in patients with sickle cell disease: Multiple-site vaso-occlusive crises could be associated with lower sphingolipid levels.
Alp, Gokce; Oztas, Yesim; Yalcinkaya, Ahmet; Ozel, Selinay; Yildirim, Nazim; Unal, Selma.
Afiliación
  • Alp G; Faculty of Engineering, Department of Chemical Engineering, Hacettepe University, Ankara, Turkey.
  • Oztas Y; Faculty of Medicine, Department of Medical Biochemistry, Hacettepe University, Ankara, Turkey.
  • Yalcinkaya A; Faculty of Medicine, Department of Medical Biochemistry, Hacettepe University, Ankara, Turkey.
  • Ozel S; Faculty of Science, Department of Chemistry, Hacettepe University, Ankara, Turkey.
  • Yildirim N; Faculty of Medicine, Department of Pediatrics Hematology, Mersin University, Mersin, Turkey.
  • Unal S; Faculty of Medicine, Department of Pediatrics Hematology, Mersin University, Mersin, Turkey.
Lipids ; 59(3): 75-82, 2024 May.
Article en En | MEDLINE | ID: mdl-38332401
ABSTRACT
Although sickle cell disease (SCD) and its manifestations have been associated with various lipid alterations, there are a few studies exploring the impact of sphingolipids in SCD. In this study, we determined plasma ceramide (Cer) and sphingomyelin (CerPCho) species and investigated their association with the crisis in SCD. SCD patients (N = 27) suffering from vaso-occlusive crisis (VOC) or acute chest syndrome (ACS) were involved in this study. Blood samples were drawn at crisis and later at steady state periods. Clinical history, white blood cell count (WBC), C-reactive protein and lactate dehydrogenase (LDH) levels were recorded. 160, 180, 200, 220 Cer and 160, 180, 240 CerPCho were measured via LC-MS/MS. All measured Cer and CerPCho levels of SCD patients at crisis and steady-state were found to be similar. Inflammation-related parameters were significantly higher in patients with ACS compared to single-site VOC. Patients with multiple-site VOC were found to have significantly lower sphingolipid levels compared with those with single-site VOC, at crisis (16, 18, 24 CerPCho and 18, 22 Cer) and at steady-state (240 CerPCho and 18 Cer). Our results show that sphingolipid levels in SCD patients are similar during crisis and at steady state. However, lower sphingolipid levels appear to be associated with the development of multiple-site VOC. Since the differences were observed at both crisis and steady-state, sphingolipid level could be an underlying factor associated with crisis characteristics in patients with SCD.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Esfingolípidos / Ceramidas / Anemia de Células Falciformes Tipo de estudio: Risk_factors_studies Idioma: En Revista: Lipids Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Esfingolípidos / Ceramidas / Anemia de Células Falciformes Tipo de estudio: Risk_factors_studies Idioma: En Revista: Lipids Año: 2024 Tipo del documento: Article